🔍 PepKon recrute un Bras droit du CEO Jonathan Levy (stage ou alternance) à partir de septembre 2024. 💼 L'opportunité de contribuer activement au développement de traitements anticancéreux innovants au sein d'une équipe passionnée et expérimentée. 🎓 Descriptif du poste et compétences requises dans l'annonce ci-jointe. 📩 Pour postuler : Envoi d'un CV et d'une lettre de motivation par mail ou via l'annonce LinkedIn ( https://lnkd.in/ejBqx8f2 )
À propos
PepKon is a french biotechnology company founded in 2022. The company develops first-in-class peptides for the treatment of incurable or poor prognosis cancers. These drug-candidates come from over a decade of academic research, resulting in seven scientific publications and two patent families
- Site web
-
www.pepkon.fr
Lien externe pour PepKon
- Secteur
- Biotechnologie
- Taille de l’entreprise
- 2-10 employés
- Siège social
- Paris
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2022
Lieux
-
Principal
Paris, FR
Employés chez PepKon
Nouvelles
-
PepKon a republié ceci
The 8th Edition of the famous International Pitch Competition at the Boston Paris Biotechnology Summit™ was held 15 May 2024 At CIC CAMBRIDGE, 02142 MA, 11 AM US EDT. Congratulations to the Winner: PepKon. Led by CEO Jonathan Levy. PepKon develops first-in-class drug candidates for the treatment of incurable cancers. PKT16 is highly innovative because its mechanism of action differs from that of competitor CD47 antibodies. It is a promising drug candidate as it has displayed good activity and low toxicity during in vitro and in vivo studies. PKT16 has a competitive advantage because it is simple to manufacture by chemical synthesis Pitch Competition Design & Management: Shahin Gharakhanian, MD Acknowledgement of the 2024 Jury: Leslie Cousens. Jennifer A. Bock. Eric Evans. Jessica Foley, MS, RAC. Naji GEHCHAN, MD, MBA. Kristin King, MBA. Albert Moussa. Acknowledgement: NETVA Program [Embassy of France in the USA, Washington DC], Jean-Philippe NICOLAI (Science & Technology Attache, Boston MA). Organizing Committee Expert MD Coach: Silvia Helou, MD, MMSc. HCConsulting. Summit Producer: Soheila Gharakhanian Boston Biotechnology Summit CIC (Cambridge Innovation Center)
-
PepKon a republié ceci
Thank you Consulat général de France à Boston and Business France Healthcare - North America for the #NETVA week. It was an amazing opportunity to discover Boston's unique Biotech ecosystem and to shed light on PepKon and its next-gen treatments for patients in oncology ! Among the many great people met this week, special thanks to Jean-Philippe NICOLAI Thomas Chambrillon Marie-Astrid Sevilla Jerome Revole, Naji GEHCHAN, MD, MBA, Alain Eudaric. I was also delighted to share this program with Zakia BELAID-SANDAL, Badia FERZAZ and Cédric JAVAULT from THERANOVIR & AI-Stroke.
🚀🌟 Celebrating #NETVA 2024 Immersion Week in Boston! 🌟🚀 Last Friday, we wrapped up an exhilarating week of innovation, workshops, networking, connections, and collaborations. 🎉 🤝 On the last day of #NETVA2024, Business France Healthcare - North America orchestrated a dynamic pitching session, bringing together our NETVA startup leaders: Cédric JAVAULT from AI-Stroke, Jonathan Levy from PepKon, and Zakia BELAID-SANDAL & Badia Ferzaz from THERANOVIR. Special thanks to Jonathan Friedlander, Nathan Lee, and Daniel Flicker, Ph.D. for their invaluable time and insights! Our startups then engaged in fascinating conversations with Chris Ilsley from InnoVenture Labs , delving into the world of innovation and incubators. Their Immersive week came to an end with a fruitful meeting at Ginkgo Bioworks, Inc., located in Seaport Boston. A heartfelt thank you to everyone involved in organizing this remarkable week. Together, we’ve forged connections, sparked ideas, and paved the way for future success. Let’s continue to innovate and thrive! 🚀 France Science, Marie-Astrid Sevilla, Jerome Revole, Jean-Philippe NICOLAI, Thomas Chambrillon
-
-
-
-
-
+3
-
-
PepKon a republié ceci
🚀 Viva Technology is back! The PepKon team is thrilled to announce our participation at Europe's largest tech and startup event for its 8th edition. As a laureate of the Concours I-Lab 2023, our CEO Jonathan Levy will have the opportunity to pitch PepKon and give a feedback on #iLab2023, along with Marielle Péré, CEO of #CellEmax, and Stanislas Chesnais CEO of Xpdeep. Thank you Valérie JACOB HOARAU and Fleur Lajouanie for putting the spotlight on us ! We look forward to meeting you and discussing the future of technology and oncology treatments. 🗓 Agenda: Friday, May 24, Booth J44 with Bpifrance at 12h Parc des Expositions de la Porte de Versailles, 75015 Paris #VivaTech2024 #iLab2023 #France2030 #PepKon #BPI
-
-
🚀 Viva Technology is back! The PepKon team is thrilled to announce our participation at Europe's largest tech and startup event for its 8th edition. As a laureate of the Concours I-Lab 2023, our CEO Jonathan Levy will have the opportunity to pitch PepKon and give a feedback on #iLab2023, along with Marielle Péré, CEO of #CellEmax, and Stanislas Chesnais CEO of Xpdeep. Thank you Valérie JACOB HOARAU and Fleur Lajouanie for putting the spotlight on us ! We look forward to meeting you and discussing the future of technology and oncology treatments. 🗓 Agenda: Friday, May 24, Booth J44 with Bpifrance at 12h Parc des Expositions de la Porte de Versailles, 75015 Paris #VivaTech2024 #iLab2023 #France2030 #PepKon #BPI
-
-
PepKon a republié ceci
🌟 NETVA 2024 Immersion Week Update! 🌟 Day 2 in Boston was packed with insights and connections for our startup laureates. Cédric Javault AI-Stroke, Jonathan Levy PepKon, Zakia Belaid-Sandal, and Badia Ferzaz THERANOVIR met Anne-Raphaelle Aubry to explore US intellectual property nuances. Next, Jeanne LeClair led a tour of the Massachusetts Life Sciences Center, and Johannes Fruehauf delved into LabCentral’s incubator. The delegation then met with Benjamin Bradford who presented the pulse of Massachusetts’ life science and biotech economy. The day concluded with the AI Biotech conference at UMass Club. Special thanks to Bernstein Private Wealth Management for the invitation! 🚀🔬 We extend heartfelt gratitude to all our partners for their unwavering support of the NETVA program. Together, we’re shaping an extraordinary journey for our three innovative start-ups! 🌐🤝 France Science, Cédric JAVAULT, Jonathan Levy, Zakia BELAID-SANDAL, Badia Ferzaz, Jean-Philippe NICOLAI, Thibault Sanson
-
-
PepKon is thrilled to participate in the 9th edition of the #MEET2WIN convention organized by MATWIN, a must-attend event dedicated to innovation in oncology. PepKon is also honored to be one of the 12 finalists selected through the MATWIN accelerator program. On this occasion, philippe karoyan, our scientific co-founder, and Jonathan Levy, our CEO, will have the privilege to present to Matwin's board the latest advancements in PepKon's research, a #biotech #startup specialized in the development of #peptides in #oncology. We would like to warmly thank the MATWIN and Unicancer teams for organizing this event, and in particular Lucia ROBERT Stéphanie Dhont Boutaina Daher Muriel Dahan as well as the coaches and the Board members for their precious feedbacks and advices. Alain Thibault Jean-Yves Bonnefoy Anna Kruczynski Andy Rankin Viia Valge-Archer James Carmichael Mark Pearson Kenneth W. Hance, PhD, MPH Valérie Méresse Naegelen Laurent Debussche Alexandra (Sasha) Huhalov Art Bertelsen Jean-Pierre Bizzari Paul Moss Pedro Romero 🗓️ See you on May 16-17 📍 Bordeaux, France 📧 Contact us on our LinkedIn, we're eager to interact with you ! philippe karoyan, Jean Pascal Tranie, and Florence Allouche Aknin.
Just before the start of #MEET2WIN, the MATWIN Board will meet this week in Bordeaux to interview the 12 best projects selected through the MATWIN accelerator program! Laureates will be announced on Friday 17th at 12 pm - Michael Heim Paul van der Schueren, Altevax Biotech - Ross Breckenridge, ARJUNA Therapeutics - Philippe Berthon Michel Léonetti, Blue Bees Therapeutics - Alexander Scheer, CasInvent Pharma - Eric Chevet, Centre Eugène Marquis - Pierre Le Ber Gaël Blivet-Bailly, Minos Biosciences - Davide Croci Noushin Hadadi, Novigenix SA - Sandra Jernström Sidarth Radjou Mélodie Sassine, Okomera - philippe karoyan Jonathan Levy, PepKon - Paul Herent, M.D., Msc Pierre Manceron, Raidium - Emile Roussel, PhD Lise Clément-Demange, ReACT Therapeutics - Sasha Koniev Sergii Kolodych, Syndivia ➡️ Info & registration: www.meet2win.fr An event MATWIN Unicancer #cancer #innovation #projects
-
-
PepKon a republié ceci
📣 Bienvenue aux derniers adhérents de France Deeptech, startups prometteuses, fonds renommés et conseils experts de l'écosystème #deeptech 🚀 Nous sommes fiers d'accueillir : 7 TECHNOPOLES BRETAGNE : Association des technopoles de Bretagne AgenT-biotech : Premier diagnostic sanguin pour détecter Alzheimer Aster Capital : Fonds de capital risque Climate Tech Grapheal : Dispositifs médicaux et senseurs à base de graphène Hummink : Fabrication d'électronique nanométrique de haute précision Mascaret (anciennement Dentsu Consulting) : Cabinet de communication d'affaires Metyos : Biocapteurs portés et connectés OPUS Aerospace : Conception et opération d’engins spatiaux Partech : Fonds de capital risque PepKon : Développement de peptides pour le traitement de cancers incurables Rondol Group : Solutions d'extrusion thermofusible pour la santé SteerLight : Solutions LiDARs à onde continue modulée en fréquence STIRWELD : Soudage par friction malaxage 4.0 VIQTHOR : Solutions photoniques pour les technologies quantiques Wind Capital : Fonds de capital risque 🫸 Retrouvez tous nos membres sur notre site : https://lnkd.in/daxs-mtx #frenchtech #deeptech #FT2030 #JCLFT Michel de Lempdes Romain Roullois Hugo Hubert Matthieu Blivet Marie Corbin Baptiste Billoir Jean-Marc Bally Vincent Bouchiat Pascal Boncenne Benjamin GRANGE Alexandre Boulanger Safouane Benamer Reza Malekzadeh Jonathan Levy Victoire de Margerie Laurent Dubourg PhD ✅ François Simoens Guillaume De Giovanni Thierry Vandewalle
-
-
Opportunité de Stage ou d'Alternance en Biologie Cellulaire/Biologie Moléculaire/Biotechnologie Pepkon est à la recherche d'un(e) candidat(e) hautement motivé(e) et passionné(e) par la recherche en biologie cellulaire, moléculaire et les biotechnologies pour participer à notre projet de recherche sur la caractérisation moléculaire de la mort induite par des mimes peptidiques de la thrombospondin-1. 📩 Comment postuler : Envoyez votre CV et une lettre de motivation mettant en avant votre intérêt pour le poste et la manière dont vos compétences sont en adéquation avec nos projets. 🔍 Description du poste : - Participer activement aux expériences de biologie cellulaire et moléculaire sous la supervision de notre équipe de recherche. - Effectuer diverses techniques spécialisées, telles que les cultures cellulaires, les tests de toxicité, la cytométrie en flux, l’immunofluorescence, la PCR et les Western Blots. - Collaborer avec nos experts dans la conception expérimentale et l'analyse des données. - Tenir des registres précis et complets des procédures et des résultats expérimentaux. 🎓 Exigences et compétences requises : - Étudiant(e) en dernière année de biologie cellulaire, moléculaire, biotechnologie ou domaine connexe. - Passionné(e) par la recherche scientifique et le développement expérimental. - Compétences pratiques en techniques de laboratoire, notamment en cultures cellulaires et techniques moléculaires. - Des compétences en chimie seraient un plus. - Capacité à travailler de manière autonome et en collaboration avec une équipe. - Excellentes compétences en communication et souci du détail. 💼 Ce que nous offrons : - Une opportunité de contribuer à des recherches innovantes dans le secteur industriel et dans le développement de nouveaux traitements anticancéreux. - Une exposition à des technologies et des techniques de pointe en biologie cellulaire et moléculaire. - Collaboration avec une équipe expérimentée et passionnée. Type d'emploi : stage Lieu de travail : 25-27 Av. du Québec, 91140 Villebon-sur-Yvette (Centre François Hyafil d'Oncodesign)
-
-
PepKon a republié ceci
🌟 Neighborhood's Afterworks are about sharing thoughts, opinions, and experiences. ✨ If you missed our last one “Key Take-aways from JP Morgan 2024 Healthcare Conference”, here is a highlight video 🙌 https://lnkd.in/g4FCy9DY 💡Thank you Emmanuelle Voisin, PhD for appreciating the coherence and comprehensiveness of the panel discussion with respect to your experience at the JP Morgan conference.🙏 Thank you Jonathan Levy from PepKon, Jean-Baptiste PERNEY from Echo AI, for joining us at the event, and sharing your thoughts!🙏 Stay tuned for our next Afterwork in April!💫 Sébastien Giraudier, PhD, Soraya Sin-Monnot, Forum Shah
Neighborhood Afterwork : Key takeaways from JP Morgan's annual healthcare conference 2024
https://www.youtube.com/